Conference
Study of the impact of Charlson comorbidity index and hypertension on survival in patients with metastatic castration-resistant prostate cancer.
Abstract
111
Background: Clinical and laboratory factors, i.e. visceral metastasis, anemia, LDH, PSA, PSA-doubling time, bone scan progression, pain, performance status (PS), are recognized to be prognostic factors for overall survival (OS) in metastatic castration resistant prostate cancer (mCRPC). We sought to determine if the Charlson comorbidity Index (CCI) and hypertension (HTN) provide prognostic information independent of these …
Authors
Goyal J; Pond GR; Galsky MD; Hendricks R; Small AC; Tsao C-K; Sonpavde G
Volume
31
Pagination
pp. 111-111
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
February 20, 2013
DOI
10.1200/jco.2013.31.6_suppl.111
Conference proceedings
Journal of Clinical Oncology
Issue
6_suppl
ISSN
0732-183X